Detalhe da pesquisa
1.
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.
Cancer Immunol Immunother
; 66(9): 1163-1173, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28451790
2.
Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study.
Br J Cancer
; 115(12): 1575-1583, 2016 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27875525
3.
Human Leukocyte Antigen-DR Expression is Significantly Related to an Increased Disease-Free and Disease-Specific Survival in Patients With Cervical Adenocarcinoma.
Int J Gynecol Cancer
; 26(8): 1503-1509, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27654088
4.
From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer.
BMC Cancer
; 15: 842, 2015 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26531748
5.
Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review.
Cancers (Basel)
; 13(5)2021 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670929
6.
Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697217
7.
Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.
Cancer Res
; 81(7): 1909-1921, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500246
8.
HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.
J Immunother Cancer
; 9(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341131
9.
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.
Front Immunol
; 11: 596825, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33424844
10.
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
EBioMedicine
; 43: 253-260, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952619
11.
Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
J Immunother Cancer
; 4: 78, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895918
12.
High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.
Cancer Immunol Res
; 3(1): 48-58, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361854
13.
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'.
EBioMedicine
; 57: 102875, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32650273